Continuus Pharmaceuticals, Inc. — Form D
Continuus Pharmaceuticals, Inc. of Woburn, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-06-25. The offering totals $2.6M, of which $2.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-06-25
- Form: D
- Accession: 0001577501-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.6M
- Amount sold: $2.5M
- Remaining: $136K
- Investors: 15
- Date of first sale: 2014-06-09
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-219828
Issuer
- Name: Continuus Pharmaceuticals, Inc.
- CIK: 0001577501
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 25-R Olympia Avenue, Woburn, MA, 01801
- Phone: (781) 281-0226
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Nicola Maron | Director | Castenaso (Bologna), L6 |
| Mark Bamforth | Director | Glasgow, X0 |
| Jonathan Fleming | Director | Cambridge, MA |
| Salvatore Mascia | Director | Woburn, MA |
| Salvatore Mascia | Executive Officer | Woburn, MA |
| Bayan Takizawa | Director | Woburn, MA |
| Bernhardt Trout | Director | Woburn, MA |
| Andrea Semprini | Director | Woburn, MA |
Other filings by this issuer (2)
More